|
 |
|
 |
 |
Name:
Sector:
Chief Executive:
|
Vanda Pharmaceuticals
Healthcare
Mihael Polymeropoulos, M.D.
|
|
|
Summary:
|
Revitalizes and optimizes the development of therapeutics by
applying genetic and genomic sciences. Vanda's business is to
optimize and to discover compounds for its own clinical development.
In addition, Vanda seeks to apply its tools to discovery/development
partnerships with other drug companies.
|
|
|
Stage of Initial
Investment:
|
Venture |
Liquidity:
|
Nasdaq:
VNDA
|
|
|
|
|
|
|
|
 |
| |
9605 Medical Center Drive
Suite
300
Rockville, MD 20850
Phone: 240.599.4500
Fax: 301.294.1900 |
|
 |
|
|
|
